Related Experiment Video
Updated: Sep 28, 2025

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
Long-term effects of medication for opioid use disorder in children
Jamie Cox1, Nancy Reid, Laura Lander
1Jamie Cox practices in emergency medicine at WVU Medicine in Buckhannon, W.Va. Nancy Reid is an associate professor in the PA program at the University of Lynchburg in Lynchburg, Va. Laura Lander is an associate professor and section chief of social work at WVU Health Sciences University in Morgantown, W.Va. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Insights
Opioid maintenance therapy during pregnancy can lead to neonatal abstinence syndrome (NAS) in infants. This can impact neurocognitive development, affecting long-term outcomes like education and employment.
Area of Science:
- Neuroscience
- Developmental Psychology
- Public Health
Background:
- Opioid maintenance therapy (OMT) in pregnant individuals can lead to Neonatal Abstinence Syndrome (NAS) in newborns.
- Infants with NAS face significant risks for impaired neurocognitive development.
- These developmental deficits can have lasting consequences into adulthood, including academic and socioeconomic challenges.
Purpose of the Study:
- To discuss the neurocognitive development consequences of medicated opioid use disorder in infants and children.
- To explore methods to support the neurocognitive potential of these children into adulthood.
Main Methods:
- Literature review on neurocognitive outcomes in children exposed to OMT in utero.
- Discussion of developmental trajectories and potential interventions.
Main Results:
- Children exposed to OMT in utero and diagnosed with NAS often exhibit neurocognitive deficits.
- These deficits can manifest as difficulties in school performance, increased risk of unemployment, and higher likelihood of criminal activity.
- Early and consistent support may mitigate some of these long-term negative outcomes.
Conclusions:
- Neonatal Abstinence Syndrome resulting from maternal opioid maintenance therapy poses a serious risk to neurocognitive development.
- Intervention strategies are crucial to help affected children achieve their full potential.
- Addressing these neurodevelopmental challenges is essential for improving long-term life outcomes.
Abstract:
Opioid maintenance therapy in pregnant patients can result in children born with neonatal abstinence syndrome (NAS). These infants are at high risk for poor school performance, unemployment, and criminal activity because they never reach the neurocognitive levels of their peers. This article discusses the neurocognitive development consequences of medicated opioid use disorder on infants and children and methods to help them reach their potential into adulthood.
More Related Videos
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
Related Concept Videos
Opioid Analgesics: Morphine and Other Natural Cogeners
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Oppositional Defiant Disorder
Diagnostic Criteria and...
Factors Affecting Drug Response: Overview
Analgesia and Pain Management